Skip to content

Panoscreen I and II 0002380Recalls & reported problems

Immucor, Inc. · Panoscreen I and II is intended for use in the detection of unexpected IgG antibodies to red blood cells by manual tube method. The configuration of this product is a 2-cell screen.

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10888234000297), received between Jul 19, 2016 and Mar 12, 2019 — classified as 2 malfunctions.

The most frequently reported specific device problem is “False Negative Result” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • False Negative Result2

Patient problems

  • No Known Impact Or Consequence To Patient2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 12, 2019False Negative Result; False Negative Result

    ON (B)(6) 2019, A (B)(6) CUSTOMER SITE REPORTED AN UNEXPECTEDLY NEGATIVE ANTIBODY SCREEN WHEN TESTED WITH TEST TUBES, WHEN TESTED ON (B)(6) 2019.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8412970 ↗
  • MalfunctionJul 19, 2016False Negative Result

    ON (B)(6) 2016, A CUSTOMER SITE REPORTED UNEXPECTED NEGATIVE ANTIBODY SCREENS WHEN USING PANOSCREEN I AND II - 2 VIAL SET BY TEST TUBE METHOD.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 5805476 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page